Opdivo (Nivolumab)

Opdivo (Nivolumab) is a cancer immunotherapy that helps the immune system recognize and attack cancer cells. It works by blocking a protein called PD-1, which tumors often use to hide from immune cells. By inhibiting PD-1, Nivolumab boosts the body's natural ability to fight cancer. It is commonly used to treat various types of cancers, including melanoma, lung, and kidney cancers. While effective for some patients, it can also cause side effects due to increased immune activity. Overall, Opdivo offers a targeted approach to cancer treatment by empowering the immune system.